tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Smith, 80 are a BUY (80.81%), 19 are a HOLD (19.19%).
Analyst Thomas Smith, currently employed at LEERINK, carries an average stock price target met ratio of 44.36% that have a potential upside of 37.43% achieved within 180 days.
Thomas Smith’s has documented 183 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Industrials, Financial Services, Technology, Consumer Defensive sectors.
Most recent stock forecast was given on ABVX, Abivax SA American Depositary Shares at 30-Jun-2026.
Analyst best performing recommendations are on AXLA (AXCELLA HEALTH).
The best stock recommendation documented was for AXLA (AXCELLA HEALTH) at 12/15/2022. The price target of $6 was fulfilled within 1 day with a profit of $4.98 (45.36%) receiving and performance score of 453.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$3
$1.79 (147.93%)
$3
1 years 10 months 5 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
2 years 1 months 11 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
2 years 6 months 14 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
2 years 7 months 13 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
3 years 2 months 20 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Thomas Smith is most bullish on?
Which stock is Thomas Smith is most reserved on?
What Year was the first public recommendation made by Thomas Smith?
